Status:
UNKNOWN
Chronic Migraine Prophylaxis: Ultrasound-Guided Greater Occipital Nerve Block Versus Medical Treatment
Lead Sponsor:
Tanta University
Conditions:
Greater Occipital Nerve Block
Medical Treatment
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this work is to assess the efficacy of ultrasound guided greater occipital nerve block either by local anesthetic or by botulinum toxin in comparison to medical treatment in prevention of c...
Detailed Description
Primary headache disorders, particularly migraine and tension-type headache (TTH) are common worldwide and commonly result in widespread and substantial disability. Chronic migraine (CM) is defined as...
Eligibility Criteria
Inclusion
- Age \> 18 years old.
- Both sexes.
- Patients with chronic migraine.
Exclusion
- Age less than 18 years.
- Patients with medication overuse headache.
- Patients who had used acute pain medications within 24 hours prior to the study visit.
- History of injury to the area of the GON.
- Any prior adverse reactions to local anesthetics.
- Patients with impaired sensation in the occipital area.
- Any neurological or dermatological disease that may have affected skin sensation, bleeding tendency, any skull defect.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06122545
Start Date
May 1 2022
End Date
May 1 2024
Last Update
November 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University
Tanta, El-Gharbia, Egypt, 31527